Table 8.

Disease dynamics: Estimate of the number of people infected during the sampling window, which includes individuals who are symptomatic, asymptomatic, and recovered.

Capacity of the STP (MLD)	Per person contribution to STP (107 copies/mL faeces)	Method 1	Method 2	Per person contribution to STP (106 copies/mL faeces)	Method 1	Method 2	Per person contribution to STP (105 copies/mL faeces)	Method 1	Method 2
10	120	109	116	12	1091	1164	1.20	10,909	11,636
20	60	19	21	6	194	207	0.60	1942	2071
30	40	110	117	4	1096	1169	0.40	10,961	11,692
10	120	5	6	12	52	55	1.20	517	551
10	120	191	204	12	1912	2039	1.20	19,116	20,391
339	4	7352	7842	0.35	73,521	78,423	0.04	735,213	784,227
2.5	480	46	49	48	458	489	4.80	4582	4888
172	7	1701	1814	0.7	17,009	18,143	0.07	170,092	181,432
30	40	792	845	4	7918	8446	0.40	79,177	84,456
Total (603.5 MLD)		10,325	11,013	Total (603.5 MLD)	103,251	110,134	Total (603.5 MLD)	1,032,510	1,101,344
Total (1800 MLD)		30,796	32,849	Total (1800 MLD)	307,956	328,487	Total (1800 MLD)	3,079,565	3,284,869
Average estimate of infected individuals		31,822			318,222			3,182,217
Estimate of the population in active phase of the infection		12,729			127,289			1,272,887